MedTrace Logo

Glycosylation of Exosomes in Prostate and Urothelial Carcinoma

NCT04960956 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2022-03-14

No results posted yet for this study

Summary

The purpose of this study is to collect a urine sample from patients with prostate and urothelial (bladder) cancer and healthy volunteers who do not have cancer, so that researchers can perform studies on microcellular structures called exosomes that may eventually lead to a new type of urinary biomarker test for prostate and urothelial cancer.

Conditions

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Roberto Pili, MD · Indiana University School of Medicine, Indiana University Simon Cancer Center

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-13
Primary Completion
2017-02-02
Completion
2017-02-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04960956 on ClinicalTrials.gov